An eligible responsible person (RP) is a required part of the EU, GB and NI cosmetics frameworks. Establish the actual market and supply arrangement before deciding who holds that role. This guide helps buyers verify responsibilities, access and handover; it is not a professional determination for a specific company or product.
What Is a Responsible Person?
The RP is the eligible natural or legal person responsible for specified cosmetic compliance duties. The establishment requirement differs by route: GB uses a UK-established RP, while EU and NI arrangements follow their applicable rules. The role is not a blanket transfer of every other party’s liability or an obligation to establish an RP in each EU destination country.
The core duties of the Responsible Person include:
- Product Safety: Ensuring the product is safe for human health when used under normal or reasonably foreseeable conditions.
- Product file: Maintain the required PIF and ensure lawful accessibility; the RP need not be the only person holding an authorized copy.
- Notification: Complete and maintain the applicable notification; do not describe it as product approval.
- Ongoing Surveillance: Monitoring for any undesirable effects and taking corrective action if necessary, including market withdrawals.
- Label review: Ensure applicable labeling, including appropriate RP identity/address and any permitted presentation exceptions.
For private label or custom manufacture, determine the role under the applicable manufacturer/importer/distributor provisions. Where designation is required or chosen, confirm valid written appointment and acceptance. A contract allocating work does not automatically remove statutory duties from other parties.
Core Responsibilities and Why They Matter to Buyers
Translate the applicable RP duties into named procurement and market-release gates. Do not equate every development shipment with market placement or describe RP issues as the most common border-detainment cause without evidence. Obtain qualified review of the actual supply route.
1. The Product Information File (PIF)
The PIF is a controlled, current file linked to the product. It must be readily accessible as required; no universal three-day allowance is established here. Its statutory categories include the product description, CPSR, manufacturing method/GMP statement, claim evidence where justified and animal-testing information. Supporting assessment inputs include:
- A CPSR signed by a qualified safety assessor.
- Full qualitative and quantitative formula (Q/Q).
- Physicochemical and microbiological specifications.
- Relevant stability, compatibility and microbiological evidence or justified approach; these are distinct topics, not all a “challenge test.”
- Evidence of claimed effects.
- Data on undesirable effects and serious undesirable effects (SUE).
2. The Cosmetic Product Safety Report (CPSR)
The CPSR has Part A safety information and Part B qualified assessment. Verify the assessor’s legally recognized qualifications, the report’s signature/date and the actual formula, package, exposure and variant scope. The qualification is not limited to the job title “toxicologist,” and the report does not itself settle every separate legal obligation.
3. Portal Notification
Complete the applicable notification before market placement and keep it current. The portal conveys information to authorities; a reference number is not government approval, proof of safety or a waiver of other duties.
- EU: Cosmetic Product Notification Portal (CPNP).
- GB: SCPN. For NI, the applicable route is CPNP, with eligible NI/EU RP arrangements.
Who Can Be the Responsible Person?
Determine the role from the actual supply chain and establishment, not solely from a marketing title such as “authorized representative.” Check the applicable legal provisions and any valid designation before printing the RP details.
| Supply arrangement | Role question | Evidence to retain |
|---|---|---|
| Manufacturer | Where established, where made and how placed on market? | Applicable default role or valid designation |
| Importer | Who introduces the product into the identified market? | Import/supply chain and RP arrangement |
| Distributor/own brand | Does own-brand supply or modification trigger RP status? | Actual label/change decision; translation assessed separately |
| Designated person | Eligible establishment and required written acceptance? | Mandate, covered products, duties and access; no blanket liability release |
An overseas brand does not automatically need to buy a separate third-party service: an eligible importer or another legally appropriate person may hold the role. Verify the arrangement, written designation where required, accepted duties and access before market placement.
What Happens If There Is No Responsible Person?
Failure to establish the required RP or meet related duties can lead to regulatory action. The response depends on the product, risk and circumstances; do not assume automatic personal prosecution, immediate recall or guaranteed border rejection:
- Supply restrictions: Authorities may act on applicable non-compliance; review the actual facts and any corrective-action request.
- Corrective action: Required measures can include correction, withdrawal or recall as appropriate; maintain access and response arrangements.
- Separate duties: Assess the legal responsibilities of each party; outsourcing tasks does not guarantee immunity or determine personal liability.
Appointment and handover review checklist
| Agreement topic | Questions to resolve |
|---|---|
| Market and product scope | GB, NI or EU? Exact products, variants, formula/package versions and legal person? |
| Role and acceptance | Default statutory role or designated arrangement? Written mandate/acceptance where required? |
| Address and access | Eligible establishment, label address, PIF location, secure full access and authority-response owner? |
| Work and fees | Notification, file maintenance, safety coordination, incident/corrective actions; who does each task and what is charged? |
| Changes and termination | Who reviews changes, notifies updates, retains records and transfers access to a successor without gaps? |
| Accountability | How are statutory duties preserved alongside contractual indemnity, insurance and task allocation? Obtain legal review. |
Primary sources checked on 10 October 2026: EU Cosmetics Regulation, including Articles 4–6 and 11–13, GB guidance and NI guidance. These establish route-specific responsibilities; a regulatory professional must verify the actual arrangement.
Frequently Asked Questions
Can the manufacturer be my Responsible Person?
A manufacturer can hold the role only where the applicable establishment and role conditions are met. Administrative help from an overseas factory does not itself make that factory the EU, GB or NI responsible person. Check the named legal person and arrangement, not only the factory’s geographic label.
What is the difference between a distributor and a Responsible Person?
Distributors have their own duties. Supplying under their own name/trademark or making a modification that may affect compliance can trigger RP status under the applicable rules. Translation of required information is not, by itself, treated as such a compliance-affecting modification under EU Article 4; other distributor or notification duties may still apply.
Do I need a separate Responsible Person for the UK and the EU?
Distinguish GB from NI. GB requires an eligible UK-established RP arrangement; EU and NI use the applicable EU/NI eligibility rules. The same organization may meet more than one route through an appropriate establishment/role arrangement, but do not assume one address or notification automatically covers all markets. Review qualifying NI goods separately.
What evidence proves I have a valid RP arrangement?
Keep evidence of the legally applicable role, eligible establishment, product scope and required information access. Include a written designation and acceptance where required for the arrangement, approved label details and relevant notification records. A mandate or portal reference alone is not proof that all duties are fulfilled.
Identify the RP structure early enough to inform label and market-release decisions. For a manufacturing discussion, confirm which documentation the supplier can provide and which statutory or professional services need a separate arrangement; no complete RP service is promised here.